🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

27 Gram(s) Serving Size
34 Servings
Botanical with Nutrients Product Type
17% Evidence Coverage

Supplement Facts — Evidence Check

Calories
110 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Cholesterol
55 mg (18% DV)
Total Carbohydrates
2 Gram(s) (1% DV)
Protein
20 Gram(s)
Calcium
94 mg (7% DV)
Iron
0.67 mg (4% DV)
86 mg (7% DV)
✅ Within RDA (0.1× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 86mg UL 4000mg
21 mg (5% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 21mg
Sodium
80 mg (4% DV)
Potassium
120 mg (3% DV)
Stevia Leaf Extract
250 mg

Other Ingredients

Whey Protein Concentrate Cocoa, Powder Natural Flavors Sunflower Lecithin

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested use 27 grams About 1 scoop of whey protein 6-8 fl. oz Cold water, milk or another beverage 30 seconds Stir, shake or blend until dissolved

⚠️ Warnings & Precautions

Keep out of reach of children.

Do not purchase if seal is broken.

Consult with a physician if you are pregnant, breastfeeding, or have kidney or liver disease.

Allergens: Milk

🧪 Formulation Notes

Build lean muscle Post-Workout support

Gluten free Soy free Preservative free Aspartame free Non GMO

20 grams protein 2 grams carbs 110 calories

Proprietary Filtration Process

Additional Information

GMP Registered Facility GMP Registered

Protect from heat, light and moisture. Store at 15-30 degrees C (59-86 degrees F).

Visit primegenix.com/rewards and save on your next PrimeGENIX order!

Amino Acid Profile Based on typical values per 100g Alanine 3650 mg Arginine 1879 mg Aspartic Acid 8177 mg Cysteine 1348 mg Glutamic Acid 12767 mg Glycine 1340 mg Histidine 1409 mg Isoleucine 4813 mg Leucine 7939 mg Lysine 6922 mg Methionine 1335 mg Phenylalanine 2564 mg Proline 5490 mg Serine 3434 mg Threonine 4874 mg Tryptophan 1463 mg Tyrosine 2187 mg Valine 4143 mg At the time of testing

cGMP Facility Good Manufacturing Practice FDA Registered & Inspected Facility

Product Details

UPC / SKU 6 28043 00178 7
DSLD Entry Date 2025-08-22
Product Type Botanical with Nutrients
Form Powder
Brand PrimeGENIX
DSLD ID 336136
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →